Cargando…
A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells
In addition to their stem/progenitor properties, mesenchymal stem cells (MSCs) also exhibit potent effector (angiogenic, antiinflammatory, immuno-modulatory) functions that are largely paracrine in nature. It is widely believed that effector functions underlie most of the therapeutic potential of MS...
Autores principales: | Boregowda, Siddaraju V., Krishnappa, Veena, Haga, Christopher L., Ortiz, Luis A., Phinney, Donald G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776067/ https://www.ncbi.nlm.nih.gov/pubmed/26981553 http://dx.doi.org/10.1016/j.ebiom.2015.12.020 |
Ejemplares similares
-
Basal p53 expression is indispensable for mesenchymal stem cell integrity
por: Boregowda, Siddaraju V., et al.
Publicado: (2018) -
IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet‐Induced Skeletal Involution
por: Boregowda, Siddaraju V., et al.
Publicado: (2017) -
TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs
por: Lee, Ryang Hwa, et al.
Publicado: (2023) -
Quantifiable Metrics for Predicting MSC Therapeutic Efficacy
por: Boregowda, Siddaraju V, et al.
Publicado: (2016) -
Transcriptional responses of skeletal stem/progenitor cells to hindlimb unloading and recovery correlate with localized but not systemic multi-systems impacts
por: Booker, Cori N., et al.
Publicado: (2021)